Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea.

Masa JF, Mokhlesi B, Benítez I, Gómez de Terreros Caro FJ, Sánchez-Quiroga MÁ, Romero A, Caballero C, Alonso-Álvarez ML, Ordax-Carbajo E, Gómez-García T, González M, López-Martín S, Marin JM, Martí S, Díaz-Cambriles T, Chiner E, Egea C, Barca J, Vázquez-Polo FJ, Negrín MA, Martel-Escobar M, Barbé F, Corral-Peñafiel J; Spanish Sleep Network.

Thorax. 2020 Mar 26. pii: thoraxjnl-2019-213622. doi: 10.1136/thoraxjnl-2019-213622. [Epub ahead of print]

PMID:
32217780
2.

Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome. Long-Term Pickwick Randomized Controlled Clinical Trial.

Masa JF, Mokhlesi B, Benítez I, Mogollon MV, Gomez de Terreros FJ, Sánchez-Quiroga MÁ, Romero A, Caballero-Eraso C, Alonso-Álvarez ML, Ordax-Carbajo E, Gomez-Garcia T, González M, López-Martín S, Marin JM, Martí S, Díaz-Cambriles T, Chiner E, Egea C, Barca J, Vázquez-Polo FJ, Negrín MA, Martel-Escobar M, Barbe F, Corral J; Spanish Sleep Network.

Am J Respir Crit Care Med. 2020 Mar 1;201(5):586-597. doi: 10.1164/rccm.201906-1122OC.

PMID:
31682462
3.

Comprehensive management of obstructive sleep apnea by telemedicine: Clinical improvement and cost-effectiveness of a Virtual Sleep Unit. A randomized controlled trial.

Lugo VM, Garmendia O, Suarez-Girón M, Torres M, Vázquez-Polo FJ, Negrín MA, Moraleda A, Roman M, Puig M, Ruiz C, Egea C, Masa JF, Farré R, Montserrat JM.

PLoS One. 2019 Oct 24;14(10):e0224069. doi: 10.1371/journal.pone.0224069. eCollection 2019.

4.

Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.

Masa JF, Mokhlesi B, Benítez I, Gomez de Terreros FJ, Sánchez-Quiroga MÁ, Romero A, Caballero-Eraso C, Terán-Santos J, Alonso-Álvarez ML, Troncoso MF, González M, López-Martín S, Marin JM, Martí S, Díaz-Cambriles T, Chiner E, Egea C, Barca J, Vázquez-Polo FJ, Negrín MA, Martel-Escobar M, Barbe F, Corral J; Spanish Sleep Network.

Lancet. 2019 Apr 27;393(10182):1721-1732. doi: 10.1016/S0140-6736(18)32978-7. Epub 2019 Mar 29.

PMID:
30935737
5.

Bayesian meta-analysis: The role of the between-sample heterogeneity.

Moreno E, Vázquez-Polo FJ, Negrín MA.

Stat Methods Med Res. 2018 Dec;27(12):3643-3657. doi: 10.1177/0962280217709837. Epub 2017 May 16.

PMID:
28511616
6.

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial.

Isetta V, Negrín MA, Monasterio C, Masa JF, Feu N, Álvarez A, Campos-Rodriguez F, Ruiz C, Abad J, Vázquez-Polo FJ, Farré R, Galdeano M, Lloberes P, Embid C, de la Peña M, Puertas J, Dalmases M, Salord N, Corral J, Jurado B, León C, Egea C, Muñoz A, Parra O, Cambrodi R, Martel-Escobar M, Arqué M, Montserrat JM; SPANISH SLEEP NETWORK.

Thorax. 2015 Nov;70(11):1054-61. doi: 10.1136/thoraxjnl-2015-207032. Epub 2015 Aug 26.

7.

Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.

Sánchez-de-la-Torre M, Nadal N, Cortijo A, Masa JF, Duran-Cantolla J, Valls J, Serra S, Sánchez-de-la-Torre A, Gracia M, Ferrer F, Lorente I, Urgeles MC, Alonso T, Fuentes A, Armengol F, Lumbierres M, Vázquez-Polo FJ, Barbé F; Respiratory Medicine Research Group.

Thorax. 2015 Apr;70(4):346-52. doi: 10.1136/thoraxjnl-2014-206287.

PMID:
25766689
8.

A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.

Vázquez-Polo FJ, Moreno E, Negrín MA, Martel M.

Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):317-22. doi: 10.1586/14737167.2015.1011131. Epub 2015 Feb 11. Review.

PMID:
25673174
9.

Objective Bayesian meta-analysis for sparse discrete data.

Moreno E, Vázquez-Polo FJ, Negrín MA.

Stat Med. 2014 Sep 20;33(21):3676-92. doi: 10.1002/sim.6163. Epub 2014 Apr 8.

PMID:
24710961
10.

Effectiveness of three sleep apnea management alternatives.

Masa JF, Corral J, Sanchez de Cos J, Duran-Cantolla J, Cabello M, Hernández-Blasco L, Monasterio C, Alonso A, Chiner E, Aizpuru F, Vázquez-Polo FJ, Zamorano J, Montserrat JM; Collaborating group:, Garcia-Ledesma E, Pereira R, Cancelo L, Martinez A, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Negrín MA, Embid C.

Sleep. 2013 Dec 1;36(12):1799-807. doi: 10.5665/sleep.3204.

11.

Effectiveness of sequential automatic-manual home respiratory polygraphy scoring.

Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernández-Blasco L, Monasterio C, Alonso-Fernandez A, Chiner E, Vázquez-Polo FJ, Montserrat JM; Spanish Sleep Group.

Eur Respir J. 2013 Apr;41(4):879-87. doi: 10.1183/09031936.00186811. Epub 2012 Aug 9.

12.

Comparing meta-analyses for chronic obstructive pulmonary disease.

Vázquez-Polo FJ, Moreno E, Negrín MA, Girón FJ, Martínez ML.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):277-9. doi: 10.1586/erp.11.31.

PMID:
21671696
13.

Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome.

Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernández-Blasco L, Monasterio C, Alonso A, Chiner E, Rubio M, Garcia-Ledesma E, Cacelo L, Carpizo R, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Embid C, Vázquez-Polo FJ, Negrín MA, Montserrat JM.

Thorax. 2011 Jul;66(7):567-73. doi: 10.1136/thx.2010.152272. Epub 2011 May 20.

PMID:
21602541
14.

Bayesian variable selection in cost-effectiveness analysis.

Negrín MA, Vázquez-Polo FJ, Martel M, Moreno E, Girón FJ.

Int J Environ Res Public Health. 2010 Apr;7(4):1577-96. doi: 10.3390/ijerph7041577. Epub 2010 Apr 6.

15.

Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.

Hernández MA, Vázquez-Polo FJ, González-Torre FJ, Bas EM.

Int J Technol Assess Health Care. 2009 Oct;25(4):537-45. doi: 10.1017/S0266462309990444.

PMID:
19845984
16.

Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.

Negrín MA, Vázquez-Polo FJ.

J Health Econ. 2008 Sep;27(5):1250-9. doi: 10.1016/j.jhealeco.2008.03.005. Epub 2008 Apr 12.

PMID:
18490067
17.

An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.

Vázquez-Polo FJ, Negrín M, Cabasés JM, Sánchez E, Haro JM, Salvador-Carulla L.

J Ment Health Policy Econ. 2005 Sep;8(3):153-65.

PMID:
16278503
18.
19.

Self-perceived health status of schizophrenic patients in Spain: analysis of geographic differences.

Cabasés JM, Sánchez E, Vázquez-Polo FJ, Negrín MA, Domínguez EJ.

Expert Rev Pharmacoecon Outcomes Res. 2005 Oct;5(5):531-40. doi: 10.1586/14737167.5.5.531.

PMID:
19807581
20.

Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.

Vázquez-Polo FJ, Negrín Hernández MA, López-Valcárcel BG.

Health Econ. 2005 Jun;14(6):545-57.

PMID:
15497202
21.

[Biomedical research tools: Bayesian perspective (II)].

Alamo Santana F, Vázquez Polo FJ, Rodríguez Pérez JC.

Med Clin (Barc). 2002 Sep 7;119(7):269-72. Spanish. No abstract available.

PMID:
12236988
22.

[Biomedical research tools: Bayesian perspective (I)].

Alamo Santana F, Vázquez Polo FJ, Rodríguez Pérez JC.

Med Clin (Barc). 2002 Sep 7;119(7):265-8. Review. Spanish. No abstract available.

PMID:
12236987

Supplemental Content

Loading ...
Support Center